A detailed history of Black Rock Inc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,586,637 shares of AKRO stock, worth $166 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,586,637
Previous 4,892,616 14.19%
Holding current value
$166 Million
Previous $124 Million 6.05%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$18.31 - $24.62 $12.7 Million - $17.1 Million
694,021 Added 14.19%
5,586,637 $131 Million
Q1 2024

May 10, 2024

BUY
$17.76 - $31.18 $12.6 Million - $22.2 Million
712,109 Added 17.03%
4,892,616 $124 Million
Q4 2023

Feb 13, 2024

BUY
$11.38 - $50.33 $2.31 Million - $10.2 Million
203,187 Added 5.11%
4,180,507 $97.6 Million
Q3 2023

Nov 13, 2023

BUY
$41.19 - $52.25 $27 Million - $34.3 Million
656,167 Added 19.76%
3,977,320 $201 Million
Q2 2023

Aug 11, 2023

BUY
$36.89 - $56.88 $19.8 Million - $30.6 Million
537,776 Added 19.32%
3,321,153 $155 Million
Q1 2023

May 12, 2023

BUY
$37.27 - $50.24 $926,084 - $1.25 Million
24,848 Added 0.9%
2,783,377 $106 Million
Q4 2022

Feb 13, 2023

BUY
$33.44 - $54.8 $13.8 Million - $22.6 Million
413,052 Added 17.61%
2,758,529 $151 Million
Q3 2022

Nov 14, 2022

BUY
$10.15 - $34.05 $2.58 Million - $8.66 Million
254,236 Added 12.16%
2,345,477 $79.9 Million
Q2 2022

Aug 12, 2022

BUY
$8.0 - $15.01 $1.57 Million - $2.94 Million
195,713 Added 10.32%
2,091,241 $19.8 Million
Q1 2022

May 12, 2022

SELL
$12.97 - $22.26 $630,264 - $1.08 Million
-48,594 Reduced 2.5%
1,895,528 $26.9 Million
Q4 2021

Feb 10, 2022

BUY
$19.87 - $26.24 $1.54 Million - $2.04 Million
77,565 Added 4.16%
1,944,122 $41.1 Million
Q3 2021

Nov 09, 2021

BUY
$18.65 - $25.46 $348,922 - $476,331
18,709 Added 1.01%
1,866,557 $41.7 Million
Q2 2021

Aug 11, 2021

BUY
$24.81 - $32.35 $45.8 Million - $59.8 Million
1,847,848 New
1,847,848 $45.8 Million

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.38B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.